Cargando…

Epithelial cell-adhesion molecule-directed trifunctional antibody immunotherapy for symptom management of advanced ovarian cancer

Despite advances in cytotoxic chemotherapy and surgical cytoreduction, disease recurrence continues to be a troubling problem in patients with advanced-stage epithelial ovarian cancer (EOC). Malignant ascites affects approximately 10% of patients with recurrent EOC and is associated with troublesome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eskander, Ramez N, Tewari, Krishnansu S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795053/ https://www.ncbi.nlm.nih.gov/pubmed/24124397 http://dx.doi.org/10.2147/CPAA.S45885

Ejemplares similares

Emerging treatment options for management of malignant ascites in patients with ovarian cancer
por: Eskander, Ramez N, et al.
Publicado: (2012)

Beyond angiogenesis blockade: targeted therapy for advanced cervical cancer
por: Eskander, Ramez N., et al.
Publicado: (2014)

Fifth annual workshop of cytoreductive surgery for advanced ovarian cancer and peritoneal surface malignancies
por: Tewari, Krishnansu S.
Publicado: (2016)

Novel MSH2 Mutation in the First Report of a Vietnamese–American Kindred with Lynch Syndrome
por: Eskander, Ramez N., et al.
Publicado: (2015)

Targeted treatment of advanced ovarian cancer: spotlight on rucaparib
por: Pearre, Diana C, et al.
Publicado: (2018)

Immunotherapy as a treatment strategy in advanced stage and recurrent endometrial cancer: review of current phase III immunotherapy clinical trials
por: Eskander, Ramez N., et al.
Publicado: (2021)

Characterisation of the new EpCAM-specific antibody HO-3: implications for trifunctional antibody immunotherapy of cancer
por: Ruf, P, et al.
Publicado: (2007)

Novel Monoclonal Antibodies for Cancer Treatment: The Trifunctional Antibody Catumaxomab (Removab(®))
por: Seimetz, Diane
Publicado: (2011)

Expansion microscopy with carboxylic trifunctional linkers: Expansion microscopy with carboxylic trifunctional linkers
por: Chen, Xuecheng, et al.
Publicado: (2022)

Toll-like receptor 8: augmentation of innate immunity in platinum resistant ovarian carcinoma
por: Brueseke, Taylor J, et al.
Publicado: (2013)

Immunotherapy Advances for Epithelial Ovarian Cancer
por: Hartnett, Erin G., et al.
Publicado: (2020)

Immunotherapy in endometrial cancer - an evolving therapeutic paradigm
por: Longoria, Teresa C., et al.
Publicado: (2015)

Anti-angiogenesis therapy, synthetic lethality, and checkpoint inhibition in ovarian cancer: state of the science and novel combinations
por: Liu, Marisa C, et al.
Publicado: (2018)

Erratum to: Immunotherapy in endometrial cancer - an evolving therapeutic paradigm
por: Longoria, Teresa C., et al.
Publicado: (2016)

Bevacizumab in the treatment of ovarian cancer
por: Eskander, Ramez N, et al.
Publicado: (2011)

Induction of anti-tumor immunity by trifunctional antibodies in patients with peritoneal carcinomatosis
por: Ströhlein, Michael A, et al.
Publicado: (2009)

Prognostic impact of epithelial cell adhesion molecule in ovarian cancer patients
por: Lee, Maria
Publicado: (2014)

Updates on drug discovery in ovarian cancer
por: Gibson, Steven J, et al.
Publicado: (2014)

Tumor Targeting, Trifunctional Dendritic Wedge
por: Dubey, Ramin, et al.
Publicado: (2014)

GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma
por: Zirngibl, Felix, et al.
Publicado: (2021)

Oncofertility in the setting of advanced cervical cancer - A case report
por: Gordon, Catherine, et al.
Publicado: (2018)

EZH2 inhibition in ARID1A mutated clear cell and endometrioid ovarian and endometrioid endometrial cancers
por: Alldredge, Jill K., et al.
Publicado: (2017)

Therapeutic vaccination using HPV 16 E7 to eradicate CIN3
por: Tewari, Krishnansu S.
Publicado: (2019)

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial
por: Heiss, Markus M, et al.
Publicado: (2010)

Synthesis of trifunctional cyclo-β-tripeptide templates
por: Stein, Frank, et al.
Publicado: (2012)

A phase I trial of the trifunctional anti Her2 × anti CD3 antibody ertumaxomab in patients with advanced solid tumors
por: Haense, N., et al.
Publicado: (2016)

Reversible sensory neuropathy in mitochondrial trifunctional protein deficiency
por: Grünert, Sarah Catharina, et al.
Publicado: (2022)

Association of Copy Number Variation Signature and Survival in Patients With Serous Ovarian Cancer
por: Graf, Ryon P., et al.
Publicado: (2021)

Dramatic response to Laetrile and cannabidiol (CBD) oil in a patient with metastatic low grade serous ovarian carcinoma
por: Barrie, Allison M., et al.
Publicado: (2019)

Using Mitochondrial Trifunctional Protein Deficiency to Understand Maternal Health
por: Miklas, Jason W., et al.
Publicado: (2020)

Efficacy of bezafibrate in two patients with mitochondrial trifunctional protein deficiency
por: Suyama, Tomonori, et al.
Publicado: (2020)

De-implementation and substitution of clinical care processes: stakeholder perspectives on the transition to primary human papillomavirus (HPV) testing for cervical cancer screening
por: Hahn, Erin E., et al.
Publicado: (2021)

Highlights from the Gynecologic Oncology Track at the 2017 Annual Meeting of the American Society of Clinical Oncology
por: Wolford, Juliet E., et al.
Publicado: (2017)

Should adjuvant chemotherapy be formally studied among patients found to have pelvic lymph node metastases following radical hysterectomy with lymphadenectomy for early-stage cervical cancer?
por: Bujnak, Alyssa C., et al.
Publicado: (2021)

Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy
por: Macpherson, Anne M., et al.
Publicado: (2020)

Human Trifunctional Protein Alpha Links Cardiolipin Remodeling to Beta-Oxidation
por: Taylor, William A., et al.
Publicado: (2012)

A Trifunctional Linker for Palmitoylation and Peptide and Protein Localization in Biological Membranes
por: Syga, Łukasz, et al.
Publicado: (2020)

Novel HADHB mutations in a patient with mitochondrial trifunctional protein deficiency
por: Nakama, Mina, et al.
Publicado: (2020)

A trifunctional contraceptive gel enhances the safety and quality of sexual intercourse
por: Xie, Mengjie, et al.
Publicado: (2020)

Stereoselective synthesis and application of isopulegol-based bi- and trifunctional chiral compounds
por: Le, Tam Minh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c5hl1huo01f2se40jalr7sodbs